Prognostic Value of Lupus Anticoagulant and Anti–β2 Glycoprotein I Antibody in Adverse Pregnancy Outcomes
LA-RVVT, anti-β2GPI IgG, complications including hypertension, and a history of IUFD were valuable in identifying obstetric APS. The variation in test results across facilities limits the ability to establish consistent prognostic or treatment value for each aPL.
Authors
- Tamao Kitaori
- Yuichiro Fujieda (ORCID: https://orcid.org/0000-0003-4705-341X)
- Takahiro Otani (ORCID: https://orcid.org/0000-0002-4007-7817)
- Shinobu Goto (ORCID: https://orcid.org/0000-0001-8217-4757)
- Mayumi Sugiura‐Ogasawara (ORCID: https://orcid.org/0000-0002-2265-377X)
- Tatsuya Atsumi (ORCID: https://orcid.org/0000-0001-5657-962X)
- Hiroyuki Yoshihara (ORCID: https://orcid.org/0000-0001-9306-2849)
- Naomi Nishikawa
- Megumi Nonobe
Institutions
- Hokkaido University (JP)
- Nagoya City University (JP)
- University of Warwick (GB)
- Nagoya Medical Center (JP)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1002/art.43341
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.67